Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus
- PMID: 31006151
- DOI: 10.1111/exd.13946
Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus
Abstract
Oral lichen planus (OLP) is a chronic inflammatory oral mucosal disorder with T cell-mediated immunological pathogenesis. C-C motif chemokine ligand 5 (CCL5) and its receptor C-C motif chemokine receptor 5 (CCR5) play important roles in the activation and recruitment of T cells. This study sought to explore the expression and biological functions of the CCL5-CCR5 axis in OLP. We examined the expression of the CCL5-CCR5 axis in the peripheral blood and oral tissue of healthy controls and patients with OLP using quantitative real-time PCR, Simple Western assays, enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. In addition, we investigated the effects of the CCL5-CCR5 axis on the proliferation, apoptosis and migration of OLP T cells using Cell Counting Kit-8 (CCK8) assay, flow cytometry and transwell assay. We found that the expression of the CCL5-CCR5 axis was significantly elevated both in the peripheral blood and oral tissue of patients with OLP compared with healthy controls. CCL5 not only promoted OLP T-cell proliferation and migration but also inhibited OLP T-cell apoptosis. Moreover, CCR5 inhibition suppressed OLP T-cell proliferation and migration, whereas OLP T-cell apoptosis was promoted. In conclusion, our data suggest that the CCL5-CCR5 axis may be closely related to the inflammatory infiltration of T cells in OLP.
Keywords: C-C motif chemokine ligand 5; C-C motif chemokine receptor 5; T cell; oral lichen planus; pathogenesis.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus.Cytokine. 2013 Apr;62(1):141-5. doi: 10.1016/j.cyto.2013.01.020. Epub 2013 Mar 9. Cytokine. 2013. PMID: 23490419
-
FAP-α+ immunofibroblasts in oral lichen planus promote CD4+ T-cell infiltration via CCL5 secretion.Exp Dermatol. 2022 Sep;31(9):1421-1430. doi: 10.1111/exd.14613. Epub 2022 Jun 1. Exp Dermatol. 2022. PMID: 35598279
-
Potential roles of the CCL17-CCR4 axis in immunopathogenesis of oral lichen planus.J Oral Pathol Med. 2020 Apr;49(4):328-334. doi: 10.1111/jop.12928. Epub 2019 Aug 2. J Oral Pathol Med. 2020. PMID: 31322295
-
The intricate role of CCL5/CCR5 axis in Alzheimer disease.J Neuropathol Exp Neurol. 2023 Oct 20;82(11):894-900. doi: 10.1093/jnen/nlad071. J Neuropathol Exp Neurol. 2023. PMID: 37769321 Free PMC article. Review.
-
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.Int J Mol Sci. 2018 May 16;19(5):1477. doi: 10.3390/ijms19051477. Int J Mol Sci. 2018. PMID: 29772686 Free PMC article. Review.
Cited by
-
CCL5/CCR5 axis in human diseases and related treatments.Genes Dis. 2022 Jan;9(1):12-27. doi: 10.1016/j.gendis.2021.08.004. Epub 2021 Aug 26. Genes Dis. 2022. PMID: 34514075 Free PMC article. Review.
-
Oral Lichen Planus: An Update on Diagnosis and Management.Am J Clin Dermatol. 2024 Jan;25(1):35-53. doi: 10.1007/s40257-023-00814-3. Epub 2023 Sep 15. Am J Clin Dermatol. 2024. PMID: 37713153 Review.
-
Targeting CCL5 signaling attenuates neuroinflammation after seizure.CNS Neurosci Ther. 2023 Jan;29(1):317-330. doi: 10.1111/cns.14006. Epub 2022 Nov 28. CNS Neurosci Ther. 2023. PMID: 36440924 Free PMC article.
-
Expression of neutrophil extracellular trap-related proteins and its correlation with IL-17 and TNF-α in patients with oral lichen planus.PeerJ. 2024 Oct 15;12:e18260. doi: 10.7717/peerj.18260. eCollection 2024. PeerJ. 2024. PMID: 39430569 Free PMC article.
-
Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment.Front Immunol. 2023 Jan 9;13:1023213. doi: 10.3389/fimmu.2022.1023213. eCollection 2022. Front Immunol. 2023. PMID: 36700192 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources